← Back
$ANTX All transactions

AN2 Therapeutics, Inc.

▲ BUY
5 / 10

Conviction

$ Value

$10K

Shares

8,610

Price

$1

Filed

May 29

Why this score? (5/10)
  • Open market buy (+3)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

FitzPatrick Margaret M

Title

CIK

0001873879

Roles

Director

Transaction Details

Transaction Date

2025-05-28

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

8,610

Footnotes

This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.17 to $1.18 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.

Filing Info

Accession No.

0000950170-25-078982

Form Type

4

Issuer CIK

0001880438

FitzPatrick Margaret M's History

Date Ticker Type Value
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-02-20 ANTX A $0
2025-09-09 VTGN A $0
2025-05-28 ANTX $10K
2025-05-22 ANTX A $0

Other Insiders at ANTX (90d)

Insider Bought Sold Last
Zakrzewski Joseph S 2026-03-19
Spigelman Melvin K 2026-03-19
Wong Stephanie 2026-03-19
Chanda Sanjay
Chief Development Officer
2026-03-19
FitzPatrick Margaret M 2026-03-19
Easom Eric
Chief Executive Officer
2026-03-19
Day Lucy
Chief Financial Officer
2026-03-19
Aziz Kabeer 2026-04-10
Readnour Robin Shane 2026-03-19
Martin Patricia A. 2026-04-10
Marks Gilbert Lynn 2026-04-10
Eizen Joshua M
See Remarks
2026-03-19
Williams Sarah Joanne
Principal Accounting Officer
$347 2026-03-03